JENNIFER NAUMAN: Open Payments
NPI 1265087506 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,599 in 64 payments from 14 companies in 2025. Trend: 2023 $1,603 · 2024 $1,792 · 2025 $1,599
Food & beverage: $1,599
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 18 | $502 |
| ViiV Healthcare Company | 20 | $471 |
| ABBVIE INC. | 9 | $241 |
| Theratechnologies Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $55 |
| EMD Serono, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $40 |
| Antares Pharma, Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: APRETUDE, BOTOX, Yeztugo, RUKOBIA, DOVATO, EGRIFTA, CAPLYTA, VRAYLAR.
Industry payments across OH — which companies pay providers there.
